- Motley Fool•19 hours ago
GlaxoSmithKline and Novartis are two high-yield dividend stocks that might be grossly undervalued.
- Accesswire•2 days agoBlog Coverage Ionis Pharma Closed on its Collaboration Agreement with Novartis Following Clearance under the Hart-Scott-Rodino Antitrust Improvements Act
LONDON, UK / ACCESSWIRE / February 17, 2017 / Active Wall St. blog coverage looks at the headline from Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) and Novartis AG (NYSE: NVS ). On February 16, 2017, Ionis ...
- Zacks•3 days ago
Merck's (MRK) news represents the latest setback in the pharma and biotech sector's quest to find a treatment for Alzheimer's.
NVS : Summary for Novartis AG Common Stock - Yahoo Finance
Novartis AG (NVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||76.23 - 77.21|
|52 Week Range||66.93 - 83.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||27.57|
|Dividend & Yield||2.75 (3.56%)|
|1y Target Est||N/A|